HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Personality disorder comorbidity and outcome: comparison of three age groups.

AbstractBACKGROUND:
Personality disorder comorbidity has been extensively studied in young adult populations, to a lesser extent in elderly populations, and not at all in an Australian population. This study examines PD comorbidity over the life span 18-100.
AIM:
The object of this study was to examine the interactions of comorbid personality disorder and age on outcome of Axis I disorders.
METHOD:
A total of 238 consecutive consenting eligible psychiatric inpatients were assessed on admission, prior to discharge, and after 6 and 12 months as regards symptoms, function, well-being, relapse and readmission rates and social supports. Outcomes were compared for young (18-40 years old), middle-aged (41-64) and old (65+) patients.
RESULTS:
Patients improved over time symptomatically and functionally. Across all age groups patients with comorbid personality disorder had worse outcomes than those without, but improved though never to the same extent. Personality disorder was associated with increased rates of relapse and readmission in the whole sample and in the older group, but not increased length of stay. Severity of personality disorder was associated with poorer outcome.
CONCLUSION:
Personality disorder adversely affects outcomes, particularly for younger (and older) patients with psychiatric disorders independently of diagnosis and other factors.
AuthorsJanine Stevenson, Henry Brodaty, Philip Boyce, Karen Byth
JournalThe Australian and New Zealand journal of psychiatry (Aust N Z J Psychiatry) Vol. 45 Issue 9 Pg. 771-9 (Sep 2011) ISSN: 1440-1614 [Electronic] England
PMID21827347 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Comorbidity
  • Female
  • Humans
  • Male
  • Mental Disorders (diagnosis, epidemiology, therapy)
  • Middle Aged
  • Personality Disorders (diagnosis, epidemiology, therapy)
  • Psychiatric Status Rating Scales
  • Recurrence
  • Social Support
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: